[HTML][HTML] Mucosal vaccines for SARS-CoV-2: triumph of hope over experience

D Pilapitiya, AK Wheatley, HX Tan - EBioMedicine, 2023 - thelancet.com
Currently approved COVID-19 vaccines administered parenterally induce robust systemic
humoral and cellular responses. While highly effective against severe disease, there is …

[HTML][HTML] Mucosal vaccines for SARS-CoV-2: triumph of hope over experience

D Pilapitiya, AK Wheatley, HX Tan - eBioMedicine, 2023 - ncbi.nlm.nih.gov
Currently approved COVID-19 vaccines administered parenterally induce robust systemic
humoral and cellular responses. While highly effective against severe disease, there is …

[HTML][HTML] Mucosal vaccines for SARS-CoV-2: triumph of hope over experience

D Pilapitiya, AK Wheatley, HX Tan - eBioMedicine, 2023 - Elsevier
Currently approved COVID-19 vaccines administered parenterally induce robust systemic
humoral and cellular responses. While highly effective against severe disease, there is …

Mucosal vaccines for SARS-CoV-2: triumph of hope over experience

D Pilapitiya, AK Wheatley, HX Tan - EBioMedicine - pubmed.ncbi.nlm.nih.gov
Currently approved COVID-19 vaccines administered parenterally induce robust systemic
humoral and cellular responses. While highly effective against severe disease, there is …

Mucosal vaccines for SARS-CoV-2: triumph of hope over experience.

D Pilapitiya, AK Wheatley, HX Tan - Ebiomedicine, 2023 - europepmc.org
Currently approved COVID-19 vaccines administered parenterally induce robust systemic
humoral and cellular responses. While highly effective against severe disease, there is …

Mucosal vaccines for SARS-CoV-2: triumph of hope over experience

D Pilapitiya, AK Wheatley, HX Tan - 2023 - europepmc.org
Currently approved COVID-19 vaccines administered parenterally induce robust systemic
humoral and cellular responses. While highly effective against severe disease, there is …